Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(33.3%)
N/A
1(33.3%)
Early Phase 1
1(33.3%)
3Total
Phase 2(1)
N/A(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05319041Early Phase 1Completed

Herbal Medication to Treat Dry Eye in Peri/ Post-menopausal Women

Role: collaborator

NCT05563090Completed

Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools

Role: lead

NCT05275933Phase 2Completed

Efficacy of TCM Capsules Lian Hua Qing Wen Jiao Nang in Mild COVID-19 Patients

Role: lead

NCT05507619Not ApplicableUnknown

Heat and Acupuncture Randomised Controlled Trial to Manage Osteoarthritis of the Knee

Role: collaborator

All 4 trials loaded